Evidence method
Level · gp.fundamentals.debt_to_revenue
15.15% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Dec 31, 2016
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-17-000011General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
11.28% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.54% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.shares_outstanding
1.28% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
7.81% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
13.21% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
33.21% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
13.04% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.44% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.29% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 12.93%
- Current
- 11.28%
- Delta
- -1.65%
- Previous
- 18.16%
- Current
- 14.54%
- Delta
- -3.62%
- Previous
- 1.52%
- Current
- 1.28%
- Delta
- -0.24%
- Previous
- 9.35%
- Current
- 7.81%
- Delta
- -1.54%
- Previous
- 53.38%
- Current
- 13.21%
- Delta
- -40.18%
- Previous
- 32.15%
- Current
- 33.21%
- Delta
- 1.06%
- Previous
- 13.62%
- Current
- 13.04%
- Delta
- -0.58%
- Previous
- 2.39%
- Current
- 2.44%
- Delta
- 0.05%
- Previous
- 1.22%
- Current
- 1.29%
- Delta
- 0.07%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Transitioned To · WST Fundamental State →Transitioned To · WST CAPEX_INTENSITY_DECREASED →Transitioned To · WST CASH_GENERATION_DECREASED →Transitioned To · WST DILUTION_DECREASED →Transitioned To · WST GROWTH_DECREASED →Transitioned To · WST INVENTORY_PRESSURE_DECREASED →Transitioned To · WST MARGIN_INCREASED →Transitioned To · WST PROFITABILITY_DECREASED →Transitioned To · WST R_AND_D_INTENSITY_INCREASED →Transitioned To · WST SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.